During the past decade, Haemophilia Comprehensive Care Centre conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Haemophilia Comprehensive Care Centre" are "Hemophilia A With Inhibitor" (2 trials), "Hemophilia B" (2 trials) and "Hemophilia B With Inhibitor" (2 trials). Many other conditions were trialed in "Haemophilia Comprehensive Care Centre" in a lesser frequency.

Most popular intervention types in "Haemophilia Comprehensive Care Centre" are "Biological" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "APVO101" (1 trials), "Coagulation Factor IX variant" (1 trials), "Coagulation Factor VIIa variant" (1 trials) and "MarzAA" (1 trials). Other intervention names were less common.

The vast majority of trials in "Haemophilia Comprehensive Care Centre" are 2 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Haemophilia Comprehensive Care Centre". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Haemophilia Comprehensive Care Centre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Haemophilia Comprehensive Care Centre, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".